Cruise lines could offer free trial voyages to test safety

May 7, 2021
U.S. cruise ships are one step closer to setting sail again.
One way cruise lines can qualify to restart is by conducting “trial” voyages to test the efficacy of new safety measures before paying passengers come on board.
Joe Raedle/Getty Images

Waiving patents on COVID-19 vaccines no magic pill for shortage

May 6, 2021
Global vaccine distribution also depends on access to information and having enough production plants.
To ensure that lifting patent restrictions has an impact, vaccine companies need to share know-how with manufacturers around the world.
Mohd Arhaan Archer/AFP via Getty Images

U.S. backs waiving patent protections for COVID vaccines

Changing international property rules requires unanimous agreement from nations that are part of the World Trade Organization.
Until now, the U.S. had been a major holdout. But Biden’s approval doesn’t necessarily mean a waiver will move forward.
Alex Wong/Getty Images

Countries want tourists back if they're vaccinated. That may lead to vaccine passports.

May 5, 2021
What counts as proof of immunization when there's no global database to tell a fake apart from the real thing?
"The train’s left the station. It's happening," says Jen Kates, director of global health policy at the Kaiser Family Foundation. "So many countries have said they're doing this. It's just a matter of how to make it work," and how to make it as fair and equitable as possible.
Joel Saget/AFP via Getty Images

Will genetically modified vaccines make Europe rethink “Frankenfood”?

May 3, 2021
The success of COVID-19 shots could change European attitudes toward genetically-engineered crops and benefit U.S. agribusiness.
British children take part in a demonstration protesting genetically modified food in 1999.
Photo by Steve Eason/Hulton Archive/Getty Images

The upside of the vaccine rollout for the companies making shots

May 3, 2021
The resulting goodwill may prove useful to Pfizer and Moderna.
Karen Andersen, who covers biotech at Morningstar, says the potential sale of booster shots to ward off variants of COVID-19 could be profitable for Pfizer and Moderna.
Matic Zorman/Getty Images

More companies plan to incentivize vaccination rather than require it — for now

Apr 30, 2021
Nearly 90% of U.S. companies plan to encourage or require employees to get vaccinated; 65% plan to offer incentives.
Some employers are also considering how to make COVID-19 vaccinations more accessible for their employees.
Chandan Khanna/AFP via Getty Images

The future is bright… let’s make it even brighter together.

Be a Marketplace Investor with a donation in any amount today.

Could waiving patents increase the global supply of COVID-19 vaccines?

Apr 30, 2021
Advocates for waiving say letting countries make generic vaccines would help. Skeptics say it's not that simple.
Right now, we don't have nearly enough vaccine supply for the world. A big reason for that is patents, said Amy Kapczynski, a law professor at Yale.
Ariana Drehsler/AFP via Getty Images

Employers brace for vaccine vacation crunch

Apr 28, 2021
Americans are notorious for not taking vacations, but with so much pent-up demand, this year could be different.
Employers might receive a wave of employee time off requests in the near future, testing companies' flexibility.
Oli Scarff/Getty Images

Lack of paid sick time could be a barrier to vaccination

Apr 19, 2021
Low-wage workers are least likely to get paid time off and often have less predictable, flexible schedules.
Some experts are concerned low-wage workers will be forced to choose between using their limited paid sick leave for another need or using it for the vaccine.
Joseph Prezioso/AFP via Getty Images